Anavex Life SciencesAVXL 
$5.521.10%24h
1.10%24h
Global rank12000
Market cap$440.43M
Change 7d-
YTD Performance-6.44%
SP500 benchmarkUnderperform
P/E-9.20
P/S0
Revenue$0
Earnings-$47.51M
Dividend yield-
Anavex Life Sciences (AVXL) Cash on Hand
AVXL Cash on Hand in 2022: $151.02M
According to Anavex Life Sciences latest financial reports the cash on hand of AVXL is $151.02M, an increase of 1.25% to 2022. At the end of 2022 company had $149.16M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
AVXL Cash on Hand History from 2018 to 2023
-
Value:-
AVXL Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $151.02M | 1.25% |
| 2022 | $149.16M | -1.94% |
| 2021 | $152.11M | 420.04% |
| 2020 | $29.25M | 31.84% |
| 2019 | $22.19M | -3.25% |
| 2018 | $22.93M | - |
View the Top Cash on Hand Companies 
